Skip to main content

Why Jim Cramer Is Confident on a Vaccine Rollout

Publish date:
Video Rating:
Video Duration:

Moderna  (MRNA) - Get Moderna, Inc. Report is seeking an emergency use authorization from the Food & Drug Administration for its COVID-19 vaccine candidate.

Moderna said the FDA has set a meeting data of December 17 to consider its application, one week to the day after a similar date was set to assess the Emergency Use Authorization application filed last week by Pfizer.

“This positive primary analysis confirms the ability of our vaccine to prevent COVID-19 disease with 94.1% efficacy and importantly, the ability to prevent severe COVID-19 disease. We believe that our vaccine will provide a new and powerful tool that may change the course of this pandemic and help prevent severe disease, hospitalizations, and death,” said CEO Stéphane Bancel. “I want to thank the thousands of participants in our Phase 1, Phase 2 and Phase 3 studies, as well as the staff at clinical trial sites who have been on the front lines of the fight against the virus."

WATCH: Everything Jim Cramer Is Watching in the Market Monday

Latest Videos From TheStreet and Jim Cramer:

Related Videos